NEW YORK--(BUSINESS WIRE)--Bioenvision, Inc. (NasdaqGM:BIVN) today announced Mr. Yoshimaru Yamamoto has joined Bioenvision JapanCo., Ltd. as a Director and General Manager. Mr. Yamamoto brings to Bioenvision over 30 years of pharmaceutical industry and drug development expertise. The appointment is a key part of the Company’s strategy to bring Evoltra® to Japan, the second largest pharmaceutical market in the world.
